Open Accessibility Menu

Hendrick Center for Research

Hendrick Center for Research provides the development and oversight to safely and effectively conduct research across a variety of specialty areas. To help advance healthcare, Hendrick offers phase 3 clinical trials and phase 4 observation trials, gaining early access to new technology, medications and devices for improving patient outcomes. Our goal is to make research studies and trials more accessible to the diverse communities we serve.

Overseen by a committee of individuals charged with reviewing and monitoring biomedical research involving human subjects, Hendrick Center for Research works under FDA and U.S. Department of Health and Human Services (HHS) regulations.

Hendrick current research areas:

  • Cardiology
  • Infectious Disease
  • Rheumatology
  • Surgical
  • Oncology (Breast, Pancreatic, Colorectal, Lung)

Institutional Review Board Members

Name Role
Dr. Joji Varghese Committee Chair
Dr. Joshua Reed Clinical Member
Dr. Mustapha Khalife Clinical Oncologist
Emily Goolsby Clinical Member
Irene Labeck, PharmD Scientist/Pharmacist
Bruce Lampert Chaplain
Sabrina Williams Community Liaison
Danielle Goss Co-Chair/Non-voting member
Susan Greenwood, BSN, RN, VP Non-voting member
David Evans, Esp., VP Non-voting member
Anita Broxson Community Liaison
Donna Jennings Compliance
Sharn Devun Risk Management

To download the Hendrick Institutional Review Board application, click here.